[C-reactive protein and coronary heart disease: quo vadis?].
März, Winfried
[C-reactive protein and coronary heart disease: quo vadis?]. [electronic resource] - MMW Fortschritte der Medizin Oct 2009 - 127-32 p. digital
Publication Type: Journal Article; Review
1438-3276
Alleles
Apolipoproteins E--genetics
C-Reactive Protein--genetics
Cholesterol, LDL--blood
Coronary Artery Disease--drug therapy
Female
Fluorobenzenes--therapeutic use
Haplotypes--genetics
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Male
Polymorphism, Genetic--genetics
Pyrimidines--therapeutic use
Risk Factors
Rosuvastatin Calcium
Stroke--drug therapy
Sulfonamides--therapeutic use
[C-reactive protein and coronary heart disease: quo vadis?]. [electronic resource] - MMW Fortschritte der Medizin Oct 2009 - 127-32 p. digital
Publication Type: Journal Article; Review
1438-3276
Alleles
Apolipoproteins E--genetics
C-Reactive Protein--genetics
Cholesterol, LDL--blood
Coronary Artery Disease--drug therapy
Female
Fluorobenzenes--therapeutic use
Haplotypes--genetics
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Male
Polymorphism, Genetic--genetics
Pyrimidines--therapeutic use
Risk Factors
Rosuvastatin Calcium
Stroke--drug therapy
Sulfonamides--therapeutic use